UK rolls out AstraZeneca vaccine, touts first starter status

[LONDON] Britain begins vaccinating its population on Monday with the CoviD-19 shot developed by Oxford University and AstraZeneca, touting its position as the first Western country to roll out an inoculation programme against the novel coronavirus.

Britain, which is rushing to vaccinate its population faster than the United States and the rest of Europe in a bid to put the pandemic behind it, is the first country to roll out the Oxford/AstraZeneca shot.

It last year rolled out the Pfizer and Germany's BioNTech vaccine. The first person to receive the AstraZeneca/Oxford vaccine was Brian Pinker, an 82-year-old dialysis patient, at a hospital a few hundred metres away from where the vaccine was developed.

It has put more than 1 million Covid-19 vaccines into arms already - more than the rest of Europe put together, Health Secretary Matt Hancock said, adding that the roll out of the Oxford/AstraZeneca vaccine was a triumph.

"That's a triumph of British science that we've managed to get where we are," Mr Hancock told Sky. "Right at the start, we saw that the vaccine was the only way out long term." Prime Minister Boris Johnson's government has secured 100 million doses of the Oxford/AstraZeneca vaccine which can be stored at fridge temperatures between two to eight degrees, making it easier to distribute than the Pfizer shot.

Six hospitals in England will administer the first of around 530,000 doses Britain has ready. The programme will be expanded to hundreds of other British sites in the coming days, and the government hopes it will deliver tens of millions of doses within months.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL

Britain last month became the first country to use a different vaccine produced by Pfizer and BioNTech, which has to be stored at very low temperatures.

Other Western countries have taken a longer and more cautious approach to rolling out vaccines, though Russia and China have been inoculating their citizens for months with several different vaccines still undergoing late-stage trials.

China on Dec 31 approved its first Covid-19 vaccine for general public use, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm. The company said it is 7 per cent effective against the virus.

Russia said on Nov 24 its Sputnik V vaccine, developed by the Gamaleya Institute, was 91.4 per cent effective based on interim late-stage trial results. It started vaccinations in August and has inoculated more than 100,000 people so far.

India approved the Oxford/AstraZeneca vaccine on Sunday for emergency use.

REUTERS